Does Medicare Cover Wegovy? 2024 Coverage Guide

Understanding Medicare Coverage for Wegovy

If you're on Medicare and considering Wegovy for weight loss, you've likely already discovered that getting a straight answer about coverage is frustrating. The short answer: does Medicare cover Wegovy? Traditional Medicare Part D plans generally do not cover weight loss medications — but the full picture is more nuanced, and there are legitimate pathways to access.

Wegovy (semaglutide 2.4 mg) is FDA-approved specifically for chronic weight management in adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition like hypertension or type 2 diabetes. Despite this approval and robust clinical evidence from the STEP trials showing an average weight loss of 15-17% of body weight, Medicare's statutory exclusion of weight loss drugs creates a significant coverage barrier.

This guide walks through what Medicare does and doesn't cover, when exceptions apply, how Medicare Advantage differs, and what alternatives exist if you're determined to access this medication.

Why Traditional Medicare Part D Excludes Wegovy

Medicare Part D — the prescription drug benefit — is prohibited by federal law from covering medications used primarily for weight loss. This exclusion dates back to the Medicare Modernization Act of 2003, written at a time when weight loss drugs had a troubled safety record and were considered cosmetic rather than medically necessary.

Even though our understanding of obesity as a chronic metabolic disease has evolved significantly, and even though Wegovy has demonstrated cardiovascular benefits in the SELECT trial (20% reduction in major adverse cardiovascular events), the statutory exclusion remains in place.

This means that if you have Original Medicare with a standalone Part D plan, your plan will not cover Wegovy when it's prescribed for weight management — regardless of your BMI, comorbidities, or medical necessity.

The Exception: Coverage for Diabetes

Here's where it gets interesting. Medicare Part D *does* cover GLP-1 receptor agonists when they're FDA-approved and prescribed for type 2 diabetes. Ozempic (semaglutide 0.5 mg, 1 mg, or 2 mg) and Rybelsus (oral semaglutide) are both approved for diabetes and are typically covered under Part D plans.

Wegovy contains the same active ingredient as Ozempic — semaglutide — but it's approved only for weight management, not diabetes. Because of this labeling difference, Part D plans treat them differently for coverage purposes, even though the medication works the same way in your body.

If you have type 2 diabetes, your physician may prescribe Ozempic through insurance for glucose management. Weight loss is a documented effect of the medication, but the primary indication would be diabetes control. This is a legitimate clinical pathway — not a workaround — for patients who meet diagnostic criteria.

Medicare Advantage Plans: A Different Story

Medicare Advantage (Part C) plans are offered by private insurers and are not bound by the same statutory weight loss drug exclusion that applies to traditional Part D. Some Medicare Advantage plans do cover Wegovy, particularly newer plans that include robust wellness benefits.

Coverage varies significantly by:

How to Check Your Medicare Advantage Plan

If you're enrolled in a Medicare Advantage plan, don't assume Wegovy is excluded. Take these steps:

1. Review your plan's formulary — the official list of covered drugs, available on your plan's website or through Medicare.gov
2. Look for prior authorization requirements — even if Wegovy is listed, it may require pre-approval based on BMI, documented weight loss attempts, or comorbidities
3. Check the tier placement — Wegovy may be on a specialty tier with higher cost-sharing
4. Call member services — ask specifically whether Wegovy is covered for weight management, not just for diabetes

Body Good Studio offers a free insurance probability check that reviews your specific plan and provides clarity on coverage likelihood in under a minute.

Prior Authorization and Medical Necessity Criteria

Even when a Medicare Advantage plan covers Wegovy, nearly all require prior authorization. Your prescribing clinician will need to document:

Prior authorization can take 5-15 business days. If your request is denied, you have the right to appeal — and success rates improve significantly when appeals include detailed clinical notes and peer-reviewed evidence.

For members navigating complex prior authorization or facing denials, Body Good Studio's Insurance advocacy concierge provides hands-on support through the appeal process, including clinician letters and documentation review.

Out-of-Pocket Costs and Alternative Pathways

If your Medicare plan does not cover Wegovy, or if prior authorization is denied, you're not without options.

Manufacturer Savings Programs

Novo Nordisk offers the Wegovy Savings Card, which can reduce copays for commercially insured patients. However, federal law prohibits using manufacturer copay cards with any form of government insurance — including Medicare, Medicare Advantage, Medicaid, and TRICARE. This restriction is firm and applies even if you're paying out of pocket.

Cash Pay and Compounded Semaglutide

Wegovy's list price is approximately $1,349 per month. For most Medicare beneficiaries, this is not sustainable.

Compounded semaglutide — prepared by FDA-registered 503B outsourcing facilities — offers the same active ingredient at a significantly lower cost, typically $200-$400 per month depending on dose. While compounded medications are not FDA-approved in the same way brand-name drugs are, they are legal, regulated, and widely used when prepared by licensed pharmacies.

Body Good Studio's compounded semaglutide program includes clinician oversight, dosing titration, and discreet delivery, with transparent monthly pricing and no hidden fees.

Wegovy Through Medicare Advantage

If your plan does cover Wegovy, cost-sharing will depend on your tier placement. Specialty tier medications often require 25-33% coinsurance rather than a flat copay, which can still result in costs of $300-$450 per month.

For Medicare Advantage members with confirmed coverage, Wegovy through insurance via Body Good Studio includes the prescription, prior authorization support, and $75/month program management to coordinate refills and clinical check-ins.

Dual Eligibles and Medicaid Considerations

If you qualify for both Medicare and Medicaid (dual eligible), your coverage depends on your state's Medicaid formulary, not Medicare. Some state Medicaid programs cover Wegovy with prior authorization, while others exclude all weight loss medications.

As of 2024, fewer than 15 states provide robust Medicaid coverage for GLP-1 medications prescribed for weight management. Contact your state Medicaid office or managed care plan to confirm.

The Role of Telehealth in Accessing GLP-1s

Telehealth platforms like Body Good Studio streamline the process of determining eligibility, navigating insurance, and accessing treatment — whether through insurance or self-pay. Licensed clinicians can:

This model is especially valuable for Medicare beneficiaries, who may face longer wait times for specialist appointments and limited local access to obesity medicine experts. Most members receive a personalized treatment plan within 24 hours of completing an eligibility assessment.

For a quick check on whether you qualify and what your coverage options look like, you can take Body Good Studio's free 60-second quiz.

What If You're Waiting for Medicare to Change Its Policy?

Advocacy efforts are underway to remove the weight loss drug exclusion from Medicare Part D. The Treat and Reduce Obesity Act (TROA), introduced in multiple sessions of Congress, would allow Part D to cover FDA-approved obesity medications.

As of early 2024, the bill has bipartisan support but has not been passed. Even if enacted, implementation could take months to years. If you're considering Wegovy now, waiting for legislative change is not a practical strategy.

Frequently Asked Questions

Does Medicare Part D cover Wegovy for weight loss?

No. Traditional Medicare Part D plans are prohibited by federal law from covering medications prescribed primarily for weight loss, including Wegovy. This exclusion applies even if the medication is medically necessary or prescribed by a physician.

Can Medicare Advantage plans cover Wegovy?

Yes. Medicare Advantage plans are not subject to the same weight loss drug exclusion. Some Medicare Advantage plans do cover Wegovy, though coverage varies by plan, region, and year. Check your plan's formulary and prior authorization requirements.

What if I have both diabetes and obesity — will Medicare cover a GLP-1?

If you have type 2 diabetes, Medicare Part D will typically cover GLP-1 medications that are FDA-approved for diabetes, such as Ozempic or Mounjaro. Weight loss is a known effect of these medications, but the coverage is based on the diabetes indication.

Can I use a Wegovy savings card with Medicare?

No. Federal law prohibits the use of manufacturer copay assistance programs with any government insurance, including Medicare, Medicare Advantage, Medicaid, and TRICARE — even if you're paying the full cost out of pocket.

Is compounded semaglutide covered by Medicare?

Compounded medications are generally not covered by Medicare or Medicare Advantage plans. However, they are available for cash pay at a lower cost than brand-name Wegovy, typically $200-$400 per month through telehealth platforms with licensed clinician oversight.

Ready to Start Your Weight Loss Journey?

Whether you're navigating Medicare coverage, exploring compounded options, or trying to understand prior authorization, Body Good Studio's clinician-led programs make medical weight loss accessible, affordable, and personalized. Take our free 60-second quiz to see if you qualify — most members get a treatment plan in under 24 hours. All pricing is transparent, all clinicians are licensed, and all treatment is backed by the latest evidence in metabolic medicine.